Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Jun. 30, 2020		Jun. 30, 2019
Revenue
Revenue	$ 17,585	$ 20,052	$ 35,765		$ 40,261
Cost of Revenue:
Total cost of revenue	7,318	8,723	14,514		18,984
Gross Profit	10,267	11,329	21,251		21,277
Operating Expenses
Selling, general and administrative	11,995	13,811	24,422		29,135
Research and development	4,215	3,391	7,765		7,241
Amortization of acquisition-related assets	866	1,054	1,733		2,108
Impairment of intangible asset	0	3,977	0	[1]	3,977	[1]
Total operating expenses	17,076	22,233	33,920		42,461
Loss from operations	(6,809)	(10,904)	(12,669)		(21,184)
Interest expense, net	(4,773)	(4,473)	(9,430)		(8,887)
Other (expense) income, net	(6,751)	1,069	(3,297)		(1,436)
Loss from related party equity method investment	(29,918)	(2,208)	(31,702)	[1]	(4,418)	[1]
Loss from continuing operations before income taxes	(48,251)	(16,516)	(57,098)		(35,925)
Provision for income taxes	4	622	97		848
Net loss from continuing operations	(48,255)	(17,138)	(57,195)		(36,773)
(Loss) income from discontinued operations, net of tax	(34)	2,425	31,971		2,137
Net loss	$ (48,289)	$ (14,713)	$ (25,224)	[1]	$ (34,636)	[1]
Basic and diluted net income (loss) per share
Continuing operations - common stock (in dollars per share)	$ (0.44)	$ (0.15)	$ (0.52)		$ (0.33)
Discontinued operations - common stock (in dollars per share)	0	0.02	0.29		0.02
Total net income (loss) per share - common stock (in dollars per share)	$ (0.44)	$ (0.13)	$ (0.23)		$ (0.31)
Weighted average shares outstanding
Basic and diluted - common stock (shares)	110,831,456	110,209,510	110,731,925		110,057,981
Total software-related revenue
Revenue
Revenue	$ 17,521	$ 18,291	$ 35,642		$ 36,093
Cost of Revenue:
Total cost of revenue	7,059	6,898	13,903		13,909
Software-as-a-service related
Revenue
Revenue	17,521	18,291	35,642		36,093
Cost of Revenue:
Total cost of revenue	5,916	5,658	11,617		11,366
Maintenance
Cost of Revenue:
Total cost of revenue	0	97	0		167
Amortization of developed technologies
Cost of Revenue:
Total cost of revenue	1,143	1,143	2,286		2,376
Sequencing and molecular analysis
Revenue
Revenue	64	491	123		1,305
Cost of Revenue:
Total cost of revenue	259	1,177	611		3,604
Home health care services
Revenue
Revenue	0	1,270	0		2,863
Cost of Revenue:
Total cost of revenue	$ 0	$ 648	$ 0		$ 1,471

[1] The statements for the six months ended June 30, 2020 and 2019 include the Connected Care Business (see Note 4).